Nanovibronix, Inc. (NASDAQ:FEED) Stock Short Interest Drops 81.6%Defense World · Sep 25, 2026
ENvue Medical Provides Nasdaq Listing UpdateGlobeNewsWire · Sep 15, 2026
ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor OrdersGlobeNewsWire · Sep 9, 2026
ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology ExchangeGlobeNewsWire · Sep 2, 2026
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 MillionGlobeNewsWire · Aug 18, 2026
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic AcquisitionsGlobeNewsWire · Aug 12, 2026NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield. The company's business activities span across several global markets, such as the United States, Europe, Australia, India, and Israel, in addition to other territories.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 17, 2026 | – | -$23.77 | |
| May 18, 2026 | – | -$6.88 | |
| Feb 25, 2026 | – | -$1.90 | |
| Nov 14, 2025 | – | -$10.92 | |
| Aug 19, 2025 | – | -$1.24 | |
| Nov 16, 2020 | – | -$26.40 |